Hospira, Inc. Reports Third-Quarter 2013 Results
LAKE FOREST, Ill., Nov. 6, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the third quarter ended Sept. 30, 2013. Net sales for the quarter were $1.0 billion and adjusted* diluted earnings per share were $0.51. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.)
Help employers find you! Check out all the jobs and post your resume.